<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Steven Li Pharmaceutical Insights</title>
    <link>https://stevenyiqingli.com/en/insights/</link>
    <description>Reviewed articles on pharmaceutical manufacturing, technology transfer and international partnership.</description>
    <language>en</language>
    <atom:link href="https://stevenyiqingli.com/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Building Sustainable Pharmaceutical Partnerships in Southeast Asia</title>
      <link>https://stevenyiqingli.com/en/insights/sustainable-pharma-partnerships-southeast-asia.html</link>
      <guid isPermaLink="true">https://stevenyiqingli.com/en/insights/sustainable-pharma-partnerships-southeast-asia.html</guid>
      <description>A stage-gated framework for market, regulatory, technical, quality and commercial cooperation in Southeast Asia.</description>
      <dc:creator>Steven Li (李一青)</dc:creator>
      <pubDate>Sun, 19 Jul 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Driving Localized Manufacturing Through Technology Transfer</title>
      <link>https://stevenyiqingli.com/en/insights/technology-transfer-localized-manufacturing.html</link>
      <guid isPermaLink="true">https://stevenyiqingli.com/en/insights/technology-transfer-localized-manufacturing.html</guid>
      <description>A lifecycle approach to pharmaceutical technology transfer, scale-up, validation and receiving-site capability.</description>
      <dc:creator>Steven Li (李一青)</dc:creator>
      <pubDate>Sun, 19 Jul 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Quality Systems as the Foundation of Cross-Border Pharmaceutical Partnerships</title>
      <link>https://stevenyiqingli.com/en/insights/quality-systems-cross-border-partnerships.html</link>
      <guid isPermaLink="true">https://stevenyiqingli.com/en/insights/quality-systems-cross-border-partnerships.html</guid>
      <description>How clear quality governance, evidence and change control support durable cross-border pharmaceutical partnerships.</description>
      <dc:creator>Steven Li (李一青)</dc:creator>
      <pubDate>Sun, 19 Jul 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Evaluating Sterile Injectable CMO/CDMO Projects</title>
      <link>https://stevenyiqingli.com/en/insights/sterile-injectable-cmo-cdmo-project-evaluation.html</link>
      <guid isPermaLink="true">https://stevenyiqingli.com/en/insights/sterile-injectable-cmo-cdmo-project-evaluation.html</guid>
      <description>A stage-gated route from non-confidential fit screening to transfer, validation and commercial readiness.</description>
      <dc:creator>Steven Li (李一青)</dc:creator>
      <pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>CMO, CDMO or Technology Transfer? A Practical Selection Framework</title>
      <link>https://stevenyiqingli.com/en/insights/cmo-cdmo-technology-transfer-selection.html</link>
      <guid isPermaLink="true">https://stevenyiqingli.com/en/insights/cmo-cdmo-technology-transfer-selection.html</guid>
      <description>A practical framework for selecting a cooperation model by product maturity, evidence gaps, regulatory responsibility and operating end state.</description>
      <dc:creator>Steven Li (李一青)</dc:creator>
      <pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>What Responsibilities Should a Pharmaceutical Contract Manufacturing Quality Agreement Define?</title>
      <link>https://stevenyiqingli.com/en/insights/pharmaceutical-quality-agreement-responsibilities.html</link>
      <guid isPermaLink="true">https://stevenyiqingli.com/en/insights/pharmaceutical-quality-agreement-responsibilities.html</guid>
      <description>A practical responsibility matrix for quality governance, release, change, investigations, records, audits and lifecycle control.</description>
      <dc:creator>Steven Li (李一青)</dc:creator>
      <pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>What Non-Confidential Information Is Needed for a Preliminary CMO/CDMO Project Assessment?</title>
      <link>https://stevenyiqingli.com/en/insights/cmo-cdmo-preliminary-assessment-nonconfidential-information.html</link>
      <guid isPermaLink="true">https://stevenyiqingli.com/en/insights/cmo-cdmo-preliminary-assessment-nonconfidential-information.html</guid>
      <description>A safe first-contact checklist for screening project fit before sensitive technical disclosure.</description>
      <dc:creator>Steven Li (李一青)</dc:creator>
      <pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>How to Evaluate a Sterile Pharmaceutical Contract Manufacturer</title>
      <link>https://stevenyiqingli.com/en/insights/evaluating-sterile-pharmaceutical-contract-manufacturer.html</link>
      <guid isPermaLink="true">https://stevenyiqingli.com/en/insights/evaluating-sterile-pharmaceutical-contract-manufacturer.html</guid>
      <description>A site-due-diligence framework for sterility assurance, facility fit, quality systems, evidence and supply resilience.</description>
      <dc:creator>Steven Li (李一青)</dc:creator>
      <pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Due Diligence Checklist for Overseas Pharmaceutical Companies Selecting a Manufacturing Partner in China</title>
      <link>https://stevenyiqingli.com/en/insights/due-diligence-chinese-pharmaceutical-manufacturing-partner.html</link>
      <guid isPermaLink="true">https://stevenyiqingli.com/en/insights/due-diligence-chinese-pharmaceutical-manufacturing-partner.html</guid>
      <description>A staged verification framework for selecting a named Chinese legal entity and manufacturing site for a defined product and market.</description>
      <dc:creator>Steven Li (李一青)</dc:creator>
      <pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>
